Custom Search
FDA Information
Sulfasalazine was approved by the Food and Drug Administration in 1950.
Azulfidine EN-tabs® is the only formulation of sulfasalazine approved by the FDA for the treatment of both juvenile and adult RA. The enteric-coated formulation of Azulfidine EN-tabs® was specifically designed to reduce the likelihood of nausea and stomach upset.
A prescription is required for this medicine.
Please visit the official site of the FDA for further information.
Why is this medication prescribed?
Dosage and using this medicine
What special precautions should I follow?
What should I do if I forget a dose?
What side effects can this medication cause?